Please provide your email address to receive an email when new articles are posted on . A neurotech company has announced an agreement with a radiopharmaceutical firm for the rights to manufacture an ...

These pathological changes associated with Alzheimer’s disease are currently assessed using brain imaging scans or cerebrospinal fluid markers. Positron emission tomography (PET) scans are used to ...

HMC launches Qatar’s first amyloid PET-CT brain imaging to aid early Alzheimer’s detection and improve diagnosis and patient ...

Over the last two years, we’ve seen some of the most impactful scientific advancements in Alzheimer’s disease diagnostics and treatment compared to recent decades. With more accessible means of ...

Plasma phosphorylated tau 217 (p-tau217) outperformed p-tau181, p-tau231, and other blood-based biomarkers to identify which patients might benefit most from anti-amyloid Alzheimer's drugs, a cohort ...

WASHINGTON DC - JUNE 20, 2023 Jay Reinstein, who suffers from Alzheimer's, prepares to receive a PET scan at MedStar Georgetown University Hospital in Washington, DC. (Photo by Michael Robinson Chávez ...

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyze aggregates of tau pathology in more than 12,000 people from all over the world. The study ...

New research published today suggests there is a link between abnormal blood levels of amyloid — a protein associated with Alzheimer’s disease — and subtle changes in brain microstructures on a type ...

Drugs best known for helping people lose weight may also chip away at the proteins that define Alzheimer’s disease. A ...

Learning about one’s Alzheimer’s disease (AD) risk may not cause emotional distress — but it could curb motivation to adopt or maintain healthy habits to preserve brain health, according to the ...